Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens

The human Vγ9Vδ2 T cell is a unique cell type that holds great potential in immunotherapy of cancer. In particular, the therapeutic potential of this cell type in adoptive cell therapy (ACT) has gained interest. In this regard optimization of in vitro expansion methods and functional characterizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmen Olofsson, Gitte, Idorn, Manja, Carnaz Simões, Ana Micaela, Aehnlich, Pia, Skadborg, Signe Koggersbøl, Noessner, Elfriede, Debets, Reno, Moser, Bernhard, Met, Özcan, thor Straten, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208807/
https://www.ncbi.nlm.nih.gov/pubmed/34149689
http://dx.doi.org/10.3389/fimmu.2021.645131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208807/
https://www.ncbi.nlm.nih.gov/pubmed/34149689
http://dx.doi.org/10.3389/fimmu.2021.645131

Ejemplares similares